Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) study.

Sakolsky DJ, Perel JM, Emslie GJ, Clarke GN, Wagner KD, Vitiello B, Keller MB, Birmaher B, Asarnow JR, Ryan ND, McCracken JT, Strober MJ, Iyengar S, Porta G, Brent DA.

J Clin Psychopharmacol. 2011 Feb;31(1):92-7. doi: 10.1097/JCP.0b013e318204b117.

PMID:
21192150
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Venlafaxine extended-release: a review of its use in the management of major depression.

Wellington K, Perry CM.

CNS Drugs. 2001;15(8):643-69. Review.

PMID:
11524036
[PubMed - indexed for MEDLINE]
3.

Newer generation antidepressants for depressive disorders in children and adolescents.

Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD004851. doi: 10.1002/14651858.CD004851.pub3. Review.

PMID:
23152227
[PubMed - indexed for MEDLINE]
4.

[Interest of the use of pindolol in the treatment of depression: review].

Brousse G, Schmitt A, Chereau I, Eschalier A, Dubray C, Llorca PM.

Encephale. 2003 Jul-Aug;29(4 Pt 1):338-50. Review. French.

PMID:
14615704
[PubMed - indexed for MEDLINE]
5.

Pharmacotherapy of major depressive disorder in adolescents.

Masi G, Liboni F, Brovedani P.

Expert Opin Pharmacother. 2010 Feb;11(3):375-86. doi: 10.1517/14656560903527226. Review.

PMID:
20102303
[PubMed - indexed for MEDLINE]
6.

[Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].

Gourion D.

Encephale. 2008 Jan;34(1):73-81. doi: 10.1016/j.encep.2007.12.001. Epub 2008 Feb 5. Review. French.

PMID:
18514154
[PubMed - indexed for MEDLINE]
7.

[Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].

Favré P.

Encephale. 2012 Feb;38(1):86-96. doi: 10.1016/j.encep.2011.11.003. Epub 2011 Dec 10. Review. French.

PMID:
22381728
[PubMed - indexed for MEDLINE]
8.

[Escitalopram for treatment of major depressive disorder in adults].

Llorca PM, Brousse G, Schwan R.

Encephale. 2005 Jul-Aug;31(4 Pt 1):490-501. Review. French.

PMID:
16389716
[PubMed - indexed for MEDLINE]
10.

Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.

Hetrick S, Merry S, McKenzie J, Sindahl P, Proctor M.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004851. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD004851.

PMID:
17636776
[PubMed - indexed for MEDLINE]
11.

Pharmacotherapy of child and adolescent depression.

Moreno C, Roche AM, Greenhill LL.

Child Adolesc Psychiatr Clin N Am. 2006 Oct;15(4):977-98, x. Review.

PMID:
16952771
[PubMed - indexed for MEDLINE]
12.

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.

Sánchez C, Hyttel J.

Cell Mol Neurobiol. 1999 Aug;19(4):467-89. Review.

PMID:
10379421
[PubMed - indexed for MEDLINE]
13.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
[PubMed - indexed for MEDLINE]
14.
15.

Spotlight on sertraline in the management of major depressive disorder in elderly patients.

Muijsers RB, Plosker GL, Noble S.

CNS Drugs. 2002;16(11):789-94. Review.

PMID:
12383038
[PubMed - indexed for MEDLINE]
16.

Escitalopram: a pharmacoeconomic review of its use in depression.

Croom KF, Plosker GL.

Pharmacoeconomics. 2003;21(16):1185-209. Review.

PMID:
14594439
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk